Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksI-nexus Global. Regulatory News (INX)

Share Price Information for I-nexus Global. (INX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.00
Ask: 3.50
Change: 0.00 (0.00%)
Spread: 0.50 (16.667%)
Open: 3.25
High: 3.25
Low: 3.25
Prev. Close: 3.25
INX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on trading and financial position

8 Sep 2020 07:00

RNS Number : 2758Y
i-nexus Global PLC
08 September 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, DIRECTLY OR INDIRECTLY, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014

8 September 2020

i-nexus Global plc

("i-nexus" or the "Company")

Update on trading and financial position

i-nexus Global plc (AIM: INX), a leading provider of cloud-based Strategy Execution software solutions designed for the Global 5000, today provides an update on its trading and financial position in anticipation of its financial year end on 30 September.

Operational and trading update

Since the interim results announcement, management's priorities have been threefold: continuing focus on cash conservation and further reducing the operating cost base; working in close collaboration with existing customers to prepare for and implement the Summer 2020 release; and re-energising the Company's sales pipeline. The Board is pleased to report that much has been achieved on all three fronts:

 

Cash conservation:

· The monthly operating cost base has been further reduced to £360K from a peak of over £850K. As a result, the Company is now operating at monthly P&L break-even

· The Company had trade debtors exceeding £800k and a positive cash balance of approximately £190k at end July 2020

Product launch and contract wins:

· The Summer 2020 product release went live last week following intensive design and development and a collaborative programme of customer trials and workshops. The new product has been positively received by existing customers and prospects alike

· The Company has secured a new customer, on a multi-year contract, launching directly onto the new platform. In addition, a substantial Services order has been secured in advance of a Global roll out plan at an existing customer, adding to the Company's Annual Recurring Revenue ("ARR") for this financial year and next

Re-energising the sales pipeline:

· The Company's active sales pipeline has been rebuilt to pre-COVID-19 levels and now comprises live opportunities with a potential estimated total ARR value of approximately £1.8m.

 

Financing update

 

At the time of the Interim results update, the Company announced that the Board had resolved to review strategic options to introduce fresh capital to the business, in light of the difficult and uncertain trading environment caused by COVID-19. The Company has agreed with HMRC a deferral and repayment plan in respect of PAYE and National Insurance payments amounting to approximately £430K but has otherwise thus far been unable to secure access to additional funding. Based on the Company's latest cash flow projections, the Directors anticipate that the Company is likely to experience a modest cash shortfall by the end of the calendar year, but should return to a positive cash balance from February 2021 onwards, in line with i-nexus' regular seasonal cashflow profile. As a result, the Board is, as a key priority, scaling up its efforts to source new financing facilities with immediate effect.

 For further information, please contact:

i-nexus Global plc

Simon Crowther, CEO

Alyson Levett, CFO

 

Via: Alma PR

N+1 Singer (Nominated Adviser and Broker)

Sandy Fraser (Corporate Finance)

Tom Salvesen (Corporate Broking)

 

Tel: +44 (0)207 496 3000

Alma PR

Caroline Forde / Josh Royston / Robyn Fisher

Tel: +44 (0)203 405 0212

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAXNXEDFEEFA
12
Date   Source Headline
26th Feb 20245:54 pmRNSResult of AGM
26th Feb 20247:00 amRNSAGM Statement
4th Jan 20245:53 pmRNSHolding(s) in Company
20th Dec 20237:00 amRNSFinal Results
17th Oct 20237:00 amRNSCustomer Update
7th Jul 202312:34 pmRNSResult of General Meeting
21st Jun 20237:00 amRNSProposed issue of up to £0.5 million
28th Apr 20237:00 amRNSInterim Results
3rd Mar 20239:28 amRNSHolding(s) in Company
27th Feb 202311:46 amRNSResult of AGM and current trading update
20th Dec 20227:00 amRNSFinal Results
11th Nov 20222:11 pmRNSGrant of LTIP options
3rd Oct 20221:31 pmRNSGrant of LTIP options
30th Sep 20223:12 pmRNSConvertible Loan Notes Redemption Date Extension 
2nd Aug 20228:00 amRNSFurther re Board Change
30th May 20227:00 amRNSInterim Results
24th May 20224:40 pmRNSSecond Price Monitoring Extn
24th May 20224:35 pmRNSPrice Monitoring Extension
12th May 20229:54 amRNSHolding(s) in Company
6th May 20222:00 pmRNSPrice Monitoring Extension
5th May 20227:00 amRNSAppointment of CFO
28th Apr 202212:20 pmRNSHolding(s) in Company
22nd Apr 20221:52 pmRNSHolding(s) in Company
28th Feb 202212:25 pmRNSResult of AGM and Trading Update
21st Dec 20217:00 amRNSFinal Results
29th Sep 202111:10 amRNSResult of General Meeting
13th Sep 20217:00 amRNSProposed issue of up to £0.65 million
2nd Sep 20212:41 pmRNSUpdate on trading and financial position
16th Jun 20214:41 pmRNSSecond Price Monitoring Extn
16th Jun 20214:35 pmRNSPrice Monitoring Extension
26th May 20217:00 amRNSInterim Results
18th May 20214:41 pmRNSSecond Price Monitoring Extn
18th May 20214:35 pmRNSPrice Monitoring Extension
18th May 20212:05 pmRNSSecond Price Monitoring Extn
18th May 20212:00 pmRNSPrice Monitoring Extension
22nd Apr 20214:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20214:35 pmRNSPrice Monitoring Extension
22nd Apr 20212:06 pmRNSSecond Price Monitoring Extn
22nd Apr 20212:01 pmRNSPrice Monitoring Extension
20th Apr 20219:05 amRNSSecond Price Monitoring Extn
20th Apr 20219:00 amRNSPrice Monitoring Extension
20th Apr 20217:00 amRNSHolding(s) in Company
20th Apr 20217:00 amRNSStatement re Share Price Movement
19th Apr 20214:40 pmRNSSecond Price Monitoring Extn
19th Apr 20214:35 pmRNSPrice Monitoring Extension
19th Apr 20212:00 pmRNSPrice Monitoring Extension
16th Apr 20219:05 amRNSSecond Price Monitoring Extn
16th Apr 20219:00 amRNSPrice Monitoring Extension
29th Mar 20213:14 pmRNSDirector/PDMR Shareholding
25th Mar 20214:18 pmRNSResult of AGM
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.